Thermo Fisher Scientific Expands Global Pharmaceutical Production Capacity
Published 1-4-2021
Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.
Published 1-4-2021
Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.
Published 12-21-2020
Nationwide Children's Hospital is constructing a $100 million gene therapy manufacturing center in Columbus, Ohio.
Published 11-18-2020
Ultragenyx is planning to build a 100,000-sf gene therapy manufacturing facility in Bedford, Mass.
Published 11-4-2020
CPI began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom.
Published 10-26-2020
Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds.
Published 10-20-2020
Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey p
Published 9-1-2020
Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.
Published 8-19-2020
Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass.
Published 8-10-2020
CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district.
Published 8-5-2020
The Cell and Gene Therapy Catapult is planning to create the Manufacturing Innovation Centre in Braintree in the United Kingdom.